HONG KONG -- Chinese medical technology startup SiBionics has raised nearly 500 million yuan ($72 million) in a Series D round of financing to expand its development of artificial intelligence-based devices for chronic disease management.
Shenzhen-based SiBionics this week announced it had secured the new financing from lead investors Shanghai Biomedical Industrial Equity Investment Fund and Guangdong Chinese Medicine and Mass Health Fund.
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)